George Soros Cerevel Therapeutics Holdings, Inc. Transaction History
Soros Fund Management LLC
- $4.07 Billion
- Q2 2024
A detailed history of George Soros (Soros Fund Management LLC) transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Soros Fund Management LLC holds 2,151,641 shares of CERE stock, worth $0. This represents 2.16% of its overall portfolio holdings.
Number of Shares
2,151,641
Previous 1,940,201
10.9%
Holding current value
$0
Previous $82 Million
7.28%
% of portfolio
2.16%
Previous 2.04%
Shares
2 transactions
Others Institutions Holding CERE
# of Institutions
147Shares Held
127MCall Options Held
1.91MPut Options Held
2.7M-
Perceptive Advisors LLC New York, NY10.8MShares$012.77% of portfolio
-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.33MShares$03.86% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2MShares$00.04% of portfolio
-
Pentwater Capital Management LP Naples, FL1.88MShares$00.99% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...